{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:19:14Z","timestamp":1790795954259,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jneuroim.2013.08.009","type":"journal-article","created":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T04:31:04Z","timestamp":1377923464000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cladribine interferes with IL-1\u03b2 synaptic effects in experimental multiple sclerosis"],"prefix":"10.1016","volume":"264","author":[{"given":"Alessandra","family":"Musella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Mandolesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Studer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Sepman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Fresegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Haji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Matarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.08.009_bb0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-3565(24)36794-1","article-title":"MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis","volume":"282","author":"Bolton","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0010","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1523\/JNEUROSCI.5804-08.2009","article-title":"Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis","volume":"29","author":"Centonze","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/cdd.2009.179","article-title":"The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis","volume":"17","author":"Centonze","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0020","first-page":"272","article-title":"Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy","volume":"28","author":"Cianfoni","year":"2007","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00221-008-1317-9","article-title":"Distribution of parvalbumin and calretinin immunoreactive interneurons in motor cortex from multiple sclerosis post-mortem tissue","volume":"187","author":"Clements","year":"2008","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/1352458510391344","article-title":"Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study","volume":"17","author":"Cook","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0035","first-page":"391","article-title":"Emerging oral treatments in multiple sclerosis \u2014 clinical utility of cladribine tablets","volume":"6","author":"Gasperini","year":"2010","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0040","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa0902533","article-title":"A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis","volume":"362","author":"Giovannoni","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(11)70023-0","article-title":"Sustained disease-activity-free status in patients with relapsing\u2013remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis","volume":"10","author":"Giovannoni","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1476-5381.2012.02178.x","article-title":"Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis","volume":"168","author":"Grasselli","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.expneurol.2012.07.010","article-title":"TNF-\u03b1-mediated anxiety in a mouse model of multiple sclerosis","volume":"237","author":"Haji","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0060","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.nbd.2012.02.005","article-title":"GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis","volume":"46","author":"Mandolesi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0065","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1523\/JNEUROSCI.5369-12.2013","article-title":"Interleukin-1\u03b2 alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis","volume":"33","author":"Mandolesi","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.nbd.2011.05.018","article-title":"Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-\u03b1 and of IL-1\u03b2 in experimental autoimmune encephalomyelitis","volume":"43","author":"Musumeci","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6","author":"Pitt","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/014107688708000210","article-title":"Effectiveness of amantadine in reducing relapses in multiple sclerosis","volume":"80","author":"Plaut","year":"1987","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0085","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.bbi.2010.07.241","article-title":"Abnormal activity of the Na\/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis","volume":"24","author":"Rossi","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0090","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbi.2010.10.004","article-title":"Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis","volume":"25","author":"Rossi","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.22512","article-title":"Interleukin-1\u03b2 causes synaptic hyperexcitability in multiple sclerosis","volume":"71","author":"Rossi","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0100","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1177\/1352458512440207","article-title":"Inflammation inhibits GABA transmission in multiple sclerosis","volume":"18","author":"Rossi","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0105","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archneur.60.8.1082","article-title":"Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid","volume":"60","author":"Sarchielli","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/71548","article-title":"Autoimmune encephalomyelitis ameliorated by AMPA antagonists","volume":"6","author":"Smith","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/brain\/awh467","article-title":"Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3T","volume":"128","author":"Srinivasan","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0120","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1365-2362.1997.2250774.x","article-title":"Neurotransmitters in cerebrospinal fluid reflect pathological activity","volume":"27","author":"Stover","year":"1997","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-510X(95)00339-4","article-title":"Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis","volume":"137","author":"Wallstr\u00f6m","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clim.2011.05.009","article-title":"Cladribine as a therapeutic option in multiple sclerosis","volume":"142","author":"Warnke","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I","article-title":"Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives","volume":"52","author":"Zhao","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0140","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0002-9440(10)64298-8","article-title":"Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis","volume":"162","author":"Zhu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2013.08.009_bb0145","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/labinvest.2010.6","article-title":"Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE","volume":"90","author":"Ziehn","year":"2010","journal-title":"Lab. Invest."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813002300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813002300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:46Z","timestamp":1759047706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813002300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0165572813002300"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.08.009","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cladribine interferes with IL-1\u03b2 synaptic effects in experimental multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}